aterosklerozАтеросклерозAteroscleroz2078-256X2949-3633НИИТПМ-филиал ИЦиГ СО РАНateroskleroz-601Research ArticleОБЗОРЫREVIEWSИшемическая болезнь сердца у женщин: особенности диагностики и лечения. Государственное учреждение «Институт терапии им. Л. Т. Малой UAMS»Diagnostic and treatment features of ischemic heart disease in women. «The institute of therapy named after L. T. Maloy of UAMS»ВолковВ. И.VolkovV. I.

Владимир Иванович Волков, д-р мед. наук, зав. отделом

ДУ «Институт терапии им. Л. Т. Малой АМН Украины»

отдел Атеросклероза и ИБС

61039

просп. Постылева, 2а

Харьков

DU "Institute of Therapy. L. T. Maloi Academy of Medical Sciences of Ukraine"

Department of Atherosclerosis and IHD

61039

Ave. Postyleva, 2a

Kharkov

ИсаеваА. С.IsayevaA. S.

Анна Сергеевна Исаева, канд. мед. наук, с. н. с.

ДУ «Институт терапии им. Л. Т. Малой АМН Украины»

отдел Атеросклероза и ИБС

61039

просп. Постылева, 2а

Харьков

DU "Institute of Therapy L. T. Maloi Academy of Medical Sciences of Ukraine"

Department of Atherosclerosis and IHD

61039

Ave. Postyleva, 2a

Kharkov

anna_isayeva_74@yahoo.co.ukАМН УкраиныAMS of Ukraine201129032022714559Copyright © Волков В.И., Исаева А.С., 20222022Волков В.И., Исаева А.С.Volkov V.I., Isayeva A.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://ateroskleroz.elpub.ru/jour/article/view/601

   В настоящем обзоре суммированы данные современной литературы, касающиеся особенностей ишемической болезни сердца у женщин. Особенности диагностики и лечения заболевания рассмотрены с позиций гендерной медицины. Представлена не только теоретическаяинформация, но и возможности ее клинического применения.

   The overview summarizes modern data concerning ischemic heart disease in women. Diagnostic and therapy features of disease are considered from the gender medicine points of view. Not only theoretical data are given in the paper, but also their clinical practical possible use.

ишемическая болезнь сердцаженщиныдиагностикалечениеischemic heart diseasewomendiagnosistreatmentReferencesBellasi A., Raggi P., Merz C. N. B. et al. New insights into ischemic heart disease in women // Cleveland Clinic Journal of Medicine. 2007. August. Vol. 74, N 8. P. 585–594.Bellasi A., Raggi P., Merz C. N. B. et al. New insights into ischemic heart disease in women // Cleveland Clinic Journal of Medicine. 2007. August. Vol. 74, N 8. P. 585–594.Fox A. A., Nussmeier N. A. Coronary artery bypass graft surgery in women // J. Cardiothorac. Vasc. Anesth. 2004. Vol. 18. P. 344–352.Fox A. A., Nussmeier N. A. Coronary artery bypass graft surgery in women // J. Cardiothorac. Vasc. Anesth. 2004. Vol. 18. P. 344–352.Mosca L. Heart Disease Prevention in Women // Circulation. 2004. Vol. 109. P. e158–e160Mosca L. Heart Disease Prevention in Women // Circulation. 2004. Vol. 109. P. e158–e160Heras M. Ischemic Heart Disease in Women: Clinical Presentation, Non-Invasive Testing and Management of Acute Coronary Syndromes // Rev. Esp. Cardiol. 2006. Vol. 59. P. 371–381.Heras M. Ischemic Heart Disease in Women: Clinical Presentation, Non-Invasive Testing and Management of Acute Coronary Syndromes // Rev. Esp. Cardiol. 2006. Vol. 59. P. 371–381.Stramba-Badiale M., Priori S. G. Gender-specific prescription for cardiovascular diseases? // Eur. Heart J. 2005. Vol. 26 (16). Р. 1571–1572.Stramba-Badiale M., Priori S. G. Gender-specific prescription for cardiovascular diseases? // Eur. Heart J. 2005. Vol. 26 (16). Р. 1571–1572.Hemingway H., Langenberg C., Damant J. Prevalence of Angina in Women Versus Men A Systematic Review and Meta-Analysis of International Variations Across 31 Countries // Circulation. 2008. Vol. 117. P. 1526–1536.Hemingway H., Langenberg C., Damant J. Prevalence of Angina in Women Versus Men A Systematic Review and Meta-Analysis of International Variations Across 31 Countries // Circulation. 2008. Vol. 117. P. 1526–1536.McSweeney J. C., Cody M., O’Sullivan P. et al. Women’s early warning symptoms of acute myocardial infarction // Circulation. 2003. Vol. 108. P. 2619–2623.McSweeney J. C., Cody M., O’Sullivan P. et al. Women’s early warning symptoms of acute myocardial infarction // Circulation. 2003. Vol. 108. P. 2619–2623.Fox K. F. Investigation and management of chest pain // Heart. 2005. Vol. 91. P. 105–110Fox K. F. Investigation and management of chest pain // Heart. 2005. Vol. 91. P. 105–110Johnson B. D., Shaw L. J., Pepine C. J. et al. Pain predicts cardiovascular events in women without obstruc tive coronary artery disease: results from the NIH-NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE) study // Eur. Heart J. 2006. Vol. 27. P. 1408–1415.Johnson B. D., Shaw L. J., Pepine C. J. et al. Pain predicts cardiovascular events in women without obstruc tive coronary artery disease: results from the NIH-NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE) study // Eur. Heart J. 2006. Vol. 27. P. 1408–1415.Richards H. M., Reid M. E., Murray Watt G. C. Socio-economic variations in responses to chest pain: qualitative study // BMJ. 2002. June 1. Vol. 324 (7349). P. 1308.Richards H. M., Reid M. E., Murray Watt G. C. Socio-economic variations in responses to chest pain: qualitative study // BMJ. 2002. June 1. Vol. 324 (7349). P. 1308.Chaturvedi N., Rai H., Ben-Shlomo Y. Lay diagnosis and health-care-seeking behavior for chest pain in South Asians and Europeans // Lancet. 1997. Vol. 350. P. 1578–1583.Chaturvedi N., Rai H., Ben-Shlomo Y. Lay diagnosis and health-care-seeking behavior for chest pain in South Asians and Europeans // Lancet. 1997. Vol. 350. P. 1578–1583.D’Antonio B., Dupuis G., Fleet R. et al. Sex differences in chest pain and prediction of exercise induced ischemia // Ca J. Cardiol. 2003. Vol. 19. P. 515–522.D’Antonio B., Dupuis G., Fleet R. et al. Sex differences in chest pain and prediction of exercise induced ischemia // Ca J. Cardiol. 2003. Vol. 19. P. 515–522.Espinola-Klein C., Rupprecht H. J., Erbel R. et al. Tenyear outcome after coronary angioplasty in patients with single-vessel coronary artery disease and comparison with the results of the Coronary Artery Surgery Study (CASS) // Am. J. Cardiol. 2000. Vol. 85 (3). P. 321–326.Espinola-Klein C., Rupprecht H. J., Erbel R. et al. Tenyear outcome after coronary angioplasty in patients with single-vessel coronary artery disease and comparison with the results of the Coronary Artery Surgery Study (CASS) // Am. J. Cardiol. 2000. Vol. 85 (3). P. 321–326.Kaski J. C. Cardiac syndrome in women: the role of estrogen deficiency // Heart. 2006. Vol. 92 (Supll III). P. iii5-iii9Kaski J. C. Cardiac syndrome in women: the role of estrogen deficiency // Heart. 2006. Vol. 92 (Supll III). P. iii5-iii9Lerman A., Sopko G. Women and Cardiovascular Heart Disease: Clinical Implications From the Women’s Ischemia Syndrome Evaluation (WISE) Study: Are We Smarter? // J. Am. Coll. Cardiol. 2006. Vol. 47. P. S59–S62.Lerman A., Sopko G. Women and Cardiovascular Heart Disease: Clinical Implications From the Women’s Ischemia Syndrome Evaluation (WISE) Study: Are We Smarter? // J. Am. Coll. Cardiol. 2006. Vol. 47. P. S59–S62.Douglas P. S., Ginsburg G. S. The Evaluation of Chest Pain in Women // New Engl. J. Med. 1996. Vol. 334. P. 1311–1315.Douglas P. S., Ginsburg G. S. The Evaluation of Chest Pain in Women // New Engl. J. Med. 1996. Vol. 334. P. 1311–1315.Zaman J. M., Junghans C., Sekhri N. et al. Presentation of stable angina pectoris among women and South Asian people // CMAJ. 2008. September 20. Vol. 179 (7). P. 659–667.Zaman J. M., Junghans C., Sekhri N. et al. Presentation of stable angina pectoris among women and South Asian people // CMAJ. 2008. September 20. Vol. 179 (7). P. 659–667.Milner K. A., Funk M., Amold A. et al. Typical symptoms are predictive of acute coronary syndromes in women // Am. Heart J. 2002. Vol. 143. P. 283–288.Milner K. A., Funk M., Amold A. et al. Typical symptoms are predictive of acute coronary syndromes in women // Am. Heart J. 2002. Vol. 143. P. 283–288.Bugiardini R., Estrada J. L., Nikus K. et al. Gender bias in acute coronary syndromes // Curr. Vasc. Pharmacol. 2010. Mar. Vol. 8 (2). P. 276–284.Bugiardini R., Estrada J. L., Nikus K. et al. Gender bias in acute coronary syndromes // Curr. Vasc. Pharmacol. 2010. Mar. Vol. 8 (2). P. 276–284.Stangl V., Witzel V., Baumann G. et al. Current diagnostic concepts to detect coronary artery disease in women // Eur. Heart J. 2008. Vol. 29 (6). P. 707–717.Stangl V., Witzel V., Baumann G. et al. Current diagnostic concepts to detect coronary artery disease in women // Eur. Heart J. 2008. Vol. 29 (6). P. 707–717.Detry J. M., Kapita B. M., Cosyns J. et al. Diagnostic value of history and maximal exercise electrocardiography in men and women suspected of coronary heart disease // Circulation. 1977. Nov. Vol. 56(5). P. 756–761Detry J. M., Kapita B. M., Cosyns J. et al. Diagnostic value of history and maximal exercise electrocardiography in men and women suspected of coronary heart disease // Circulation. 1977. Nov. Vol. 56(5). P. 756–761Clark P., Glasser S. P., Lyman G. H. et al. Relation of results of exercise stress tests in young women to phases of the menstrual cycle // Am. J. Cardiology. 1988. Vol. 61. Issue 1. P. 197–199.Clark P., Glasser S. P., Lyman G. H. et al. Relation of results of exercise stress tests in young women to phases of the menstrual cycle // Am. J. Cardiology. 1988. Vol. 61. Issue 1. P. 197–199.Lloyd G. W., Patel N. R., McGing E. et al. Does angina vary with the menstrual cycle in women with premenopausal coronary artery disease? // Heart. 2000. Vol. 84. P. 189–192.Lloyd G. W., Patel N. R., McGing E. et al. Does angina vary with the menstrual cycle in women with premenopausal coronary artery disease? // Heart. 2000. Vol. 84. P. 189–192.Skafar D. F., Rui X., Morales J. et al. Female Sex Hormones and Cardiovascular Disease in Women // J. Clin. Endocrin. Metab. 1997. Vol. 82, N 12. P. 3913–3918.Skafar D. F., Rui X., Morales J. et al. Female Sex Hormones and Cardiovascular Disease in Women // J. Clin. Endocrin. Metab. 1997. Vol. 82, N 12. P. 3913–3918.Stoletniy L. N., Pai R. G. Value of QT Dispersion in the Interpretation of Exercise Stress Test in Women // Circulation. 1997. Vol. 96. P. 904–910.Stoletniy L. N., Pai R. G. Value of QT Dispersion in the Interpretation of Exercise Stress Test in Women // Circulation. 1997. Vol. 96. P. 904–910.Alexander K. P. et al. Value of exercise treadmill testing in women // J. Am. Coll. Cardiol. 1998. Vol. 32. P. 1657–1664.Alexander K. P. et al. Value of exercise treadmill testing in women // J. Am. Coll. Cardiol. 1998. Vol. 32. P. 1657–1664.Kwok Y. S., Kim C., Grady D. et al. Meta-analysis of exercise testing to detect coronary artery disease in women // Am. J. Cardiology. 1999. Vol. 83. P. 660–666.Kwok Y. S., Kim C., Grady D. et al. Meta-analysis of exercise testing to detect coronary artery disease in women // Am. J. Cardiology. 1999. Vol. 83. P. 660–666.Dhond M. R., Nguyen T., Whitley T. B. et al. Prognostic Value of 12-Lead Electrocardiogram During Dobutamine Stress Echocardiography // Echocardiography. 2000. Vol. 17, Issue 5. P. 429–432.Dhond M. R., Nguyen T., Whitley T. B. et al. Prognostic Value of 12-Lead Electrocardiogram During Dobutamine Stress Echocardiography // Echocardiography. 2000. Vol. 17, Issue 5. P. 429–432.Kim C., Kwok Y. S., P. Redberg H. R. Pharmacologic stress testing for coronary disease diagnosis: a meta-analysis // Am. Heart J. 2001. Vol. 142. P. 934–944.Kim C., Kwok Y. S., P. Redberg H. R. Pharmacologic stress testing for coronary disease diagnosis: a meta-analysis // Am. Heart J. 2001. Vol. 142. P. 934–944.Schannwell C. M., Lazica D., Plehn G. et al. The current status of noninvasive cardiac diagnosis in women with suspected coronary heart disease // Med. Klin. (Munich). 2002. Sep. Vol. 15, N 97 (9). P. 513–521.Schannwell C. M., Lazica D., Plehn G. et al. The current status of noninvasive cardiac diagnosis in women with suspected coronary heart disease // Med. Klin. (Munich). 2002. Sep. Vol. 15, N 97 (9). P. 513–521.Masini M., Picano E., Lattanzi F. et al. High dose dipyridamole-echocardiography test in women: correlation with exercise-electrocardiography test and coronary arteriography // J. Am. Coll. Cardiol. 1988. Vol. 12. P. 682–685.Masini M., Picano E., Lattanzi F. et al. High dose dipyridamole-echocardiography test in women: correlation with exercise-electrocardiography test and coronary arteriography // J. Am. Coll. Cardiol. 1988. Vol. 12. P. 682–685.Cortigiani L., Dodi C., Paolini E. A. et al. Prognostic value of pharmacological stress echocardiography in women with chest pain and unknown coronary artery disease // J. Am. Coll. Cardiol. 1998. Vol. 32. P. 1975–1981.Cortigiani L., Dodi C., Paolini E. A. et al. Prognostic value of pharmacological stress echocardiography in women with chest pain and unknown coronary artery disease // J. Am. Coll. Cardiol. 1998. Vol. 32. P. 1975–1981.Earnest C. P., Blair S. N., Church T. S. Age attenuated response to aerobic conditioning in postmenopausal women // Eur. J. Appl. Physiol. 2010. Sep. Vol. 110, 1. P. 75–82.Earnest C. P., Blair S. N., Church T. S. Age attenuated response to aerobic conditioning in postmenopausal women // Eur. J. Appl. Physiol. 2010. Sep. Vol. 110, 1. P. 75–82.Chang C. J., Wu C. H., Yao W. J. et al. Relationships of age, menopause and central obesity on cardiovascular disease risk factors in Chinese women // Int. J. Obes. Relat. Metab. Disord. 2000. Dec. Vol. 24 (12). P. 1699–1704.Chang C. J., Wu C. H., Yao W. J. et al. Relationships of age, menopause and central obesity on cardiovascular disease risk factors in Chinese women // Int. J. Obes. Relat. Metab. Disord. 2000. Dec. Vol. 24 (12). P. 1699–1704.Guidelines of management of stable angina pectoris. Joint task force of the European society of cardiology // Eur. Heart J. 2006. Vol. 27. P. 1341–1381.Guidelines of management of stable angina pectoris. Joint task force of the European society of cardiology // Eur. Heart J. 2006. Vol. 27. P. 1341–1381.Stempfer M. J., Golditz G. A., Willet W. C. et al. Post menopausal estrogen therapy and cardiovascular disease. Ten year follw-up from the Nurses` Health Stu dy // New Engl. J. Med. 1991. Vol. 325. P. 752–762.Stempfer M. J., Golditz G. A., Willet W. C. et al. Post menopausal estrogen therapy and cardiovascular disease. Ten year follw-up from the Nurses` Health Stu dy // New Engl. J. Med. 1991. Vol. 325. P. 752–762.Schenk-Gustafsson K. Management of menopause in the context of coronary heart disease // Maturitas. 2011. Vol. 68. P. 94–97.Schenk-Gustafsson K. Management of menopause in the context of coronary heart disease // Maturitas. 2011. Vol. 68. P. 94–97.Burke J. H., Goldberger J. J., Ehlert F. A. et al. Gender differences in heart rate before and after autonomic blockade: evidence against an intrinsic gender effect // Am. J. Med. 1996. May. Vol. 100. (5). P. 24–28.Burke J. H., Goldberger J. J., Ehlert F. A. et al. Gender differences in heart rate before and after autonomic blockade: evidence against an intrinsic gender effect // Am. J. Med. 1996. May. Vol. 100. (5). P. 24–28.Vitale C., Iellamo F., Volterrani M. et al. Heart rate control in an unselected consecutive population of outpatients with stable coronary artery disease: Analysis of the CARDIf Study Cohort // Angiology. 2010. Nov. Vol. 61(8). P. 763–767.Vitale C., Iellamo F., Volterrani M. et al. Heart rate control in an unselected consecutive population of outpatients with stable coronary artery disease: Analysis of the CARDIf Study Cohort // Angiology. 2010. Nov. Vol. 61(8). P. 763–767.Wu Q., Zhao Z., Sun H. et al. Oestrogen changed cardiomyocyte contraction and beta-adrenoceptor expression in rat hearts subjected to ischaemia-reperfusion // Exp. Physiol. 2008. Sep. Vol. 93(9). P. 1034–1043.Wu Q., Zhao Z., Sun H. et al. Oestrogen changed cardiomyocyte contraction and beta-adrenoceptor expression in rat hearts subjected to ischaemia-reperfusion // Exp. Physiol. 2008. Sep. Vol. 93(9). P. 1034–1043.Luzier A. B., Killian A., Wilton J. H. et al. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers // Clin. Pharmacol. Ther. 1999. Dec. Vol. 66 (6). P. 594–601.Luzier A. B., Killian A., Wilton J. H. et al. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers // Clin. Pharmacol. Ther. 1999. Dec. Vol. 66 (6). P. 594–601.Martin R. M., Biswas P. N., Freemantle S. N. Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies // Br. J. Clin. Pharmacol. 1998. Vol. 46 (5). P. 5–11.Martin R. M., Biswas P. N., Freemantle S. N. Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies // Br. J. Clin. Pharmacol. 1998. Vol. 46 (5). P. 5–11.King L. T., Brucker M. C. Pharmacology for women health. Health & Fitness, 2009. 1244 p.King L. T., Brucker M. C. Pharmacology for women health. Health & Fitness, 2009. 1244 p.Johnson J. A., Akers W. S., Herring V. L. et al. Gender Differences in Labetalol Kinetics: Importance of Determining Stereoisomer Kinetics for Racemic Drugs // Pharmacotherapy. 2000. Vol. 20 (6). P. 622–628.Johnson J. A., Akers W. S., Herring V. L. et al. Gender Differences in Labetalol Kinetics: Importance of Determining Stereoisomer Kinetics for Racemic Drugs // Pharmacotherapy. 2000. Vol. 20 (6). P. 622–628.Olsson G., Wikstrand J., Warnold I. et al. Metoprololinduced reduction in postinfarction mortality: pooled results from five double-blind randomized trials // Eur. Heart J. 1992. Vol. 13, Issue 1. P. 28–32.Olsson G., Wikstrand J., Warnold I. et al. Metoprololinduced reduction in postinfarction mortality: pooled results from five double-blind randomized trials // Eur. Heart J. 1992. Vol. 13, Issue 1. P. 28–32.Bonnet N., Gadois C., McCloskey E. et al. Protective effect of beta blockers in postmenopausal women: influence on fractures, bone density, micro and macroarchitecture // Bone. 2007. May. Vol. 40 (5). P. 1209–1216.Bonnet N., Gadois C., McCloskey E. et al. Protective effect of beta blockers in postmenopausal women: influence on fractures, bone density, micro and macroarchitecture // Bone. 2007. May. Vol. 40 (5). P. 1209–1216.Lahoza C., Mantillab T., Taboadac M. et al. Gender differences in evidence-based pharmacological therapy for patients with stable coronary heart disease // Cardiology. 2009. Vol. 133, Issue 3. P. 336–340.Lahoza C., Mantillab T., Taboadac M. et al. Gender differences in evidence-based pharmacological therapy for patients with stable coronary heart disease // Cardiology. 2009. Vol. 133, Issue 3. P. 336–340.http://clinicaltrials.gov/ct2/show/NCT01161823?term=postmenopausal+beta-blockers&rank=2.http://clinicaltrials.gov/ct2/show/NCT01161823?term=postmenopausal+beta-blockers&rank=2.Hsi D. H., Roshandel A., Singh N. et al. Headache response to glyceryl trinitrate in patients with and with-out obstructive coronary artery disease // Heart. 2005. Vol. 91 (9). P. 1164–1166.Hsi D. H., Roshandel A., Singh N. et al. Headache response to glyceryl trinitrate in patients with and with-out obstructive coronary artery disease // Heart. 2005. Vol. 91 (9). P. 1164–1166.Nabhan A. F., Rabie N. H. Isosorbide mononitrate versus alendronate for postmenopausal osteoporosis // Int. J. Gynaecol. Obstet. 2008. Dec. Vol. 103 (3). P. 213–216.Nabhan A. F., Rabie N. H. Isosorbide mononitrate versus alendronate for postmenopausal osteoporosis // Int. J. Gynaecol. Obstet. 2008. Dec. Vol. 103 (3). P. 213–216.Jamal S. A., Cummings S. R., Hawker G. A. Isosorbide mononitrate increases bone formation and decreases bone resorption in postmenopausal women: a randomized trial // J. Bone Miner. Res. 2004. Sep. Vol. 19 (9). P. 1512–1517.Jamal S. A., Cummings S. R., Hawker G. A. Isosorbide mononitrate increases bone formation and decreases bone resorption in postmenopausal women: a randomized trial // J. Bone Miner. Res. 2004. Sep. Vol. 19 (9). P. 1512–1517.Nabhan A. F. A randomized clinical trial of the effects of isosorbide mononitrate on bone formation and resorption in post-menopausal women: a pilot study // Hum. Reprod. 2006. May. Vol. 21 (5). P. 1320–1324.Nabhan A. F. A randomized clinical trial of the effects of isosorbide mononitrate on bone formation and resorption in post-menopausal women: a pilot study // Hum. Reprod. 2006. May. Vol. 21 (5). P. 1320–1324.Nabhan A. F., Rabie N. H. Isosorbide mononitrate versus alendronate for postmenopausal osteoporosis // Int. J. Gynaecol. Obstet. 2008. Dec. Vol. 103 (3). P. 213–216.Nabhan A. F., Rabie N. H. Isosorbide mononitrate versus alendronate for postmenopausal osteoporosis // Int. J. Gynaecol. Obstet. 2008. Dec. Vol. 103 (3). P. 213–216.Pouwels S., Lalmohamed A., van Staa T. et al. Use of organic nitrates and the risk of hip fracture: a population-based case-control study // J. Clin. Endocrinol. Metab. 2010. Apr. Vol. 95 (4). P. 1924–1931.Pouwels S., Lalmohamed A., van Staa T. et al. Use of organic nitrates and the risk of hip fracture: a population-based case-control study // J. Clin. Endocrinol. Metab. 2010. Apr. Vol. 95 (4). P. 1924–1931.Dzhanashiia P. Kh., Zhiliaev E. V., Glazunov A. V. et al. The antianginal efficacy of calcium antagonists in men and women at 60 and older. Approaches to predicting the effect of the preparations // Ter. Arkh. 1994. Vol. 66 (10). P. 75–79.Dzhanashiia P. Kh., Zhiliaev E. V., Glazunov A. V. et al. The antianginal efficacy of calcium antagonists in men and women at 60 and older. Approaches to predicting the effect of the preparations // Ter. Arkh. 1994. Vol. 66 (10). P. 75–79.Dominguez-Rodriguez A., Fard S. S., Abreu-Gonzalez P. et al. Randomised, double-blind, placebo-controlled trial of ivabradine in patients with acute coronary syndrome: effects of the If current inhibitor ivabradine on reduction of inflammation markers in patients with acute coronary syndrome–RIVIERA trial study design and rationale // Cardiovasc. Drugs. Ther. 2009. Jun. Vol. 23 (3). P. 243–247.Dominguez-Rodriguez A., Fard S. S., Abreu-Gonzalez P. et al. Randomised, double-blind, placebo-controlled trial of ivabradine in patients with acute coronary syndrome: effects of the If current inhibitor ivabradine on reduction of inflammation markers in patients with acute coronary syndrome–RIVIERA trial study design and rationale // Cardiovasc. Drugs. Ther. 2009. Jun. Vol. 23 (3). P. 243–247.Ridker P. V. et al. A randomized trial of low dose aspirin in the primary prevention of cardiovascular disease in women // New Eng. J. Med. 2005. Vol. 325 (13). P. 1293–1304.Ridker P. V. et al. A randomized trial of low dose aspirin in the primary prevention of cardiovascular disease in women // New Eng. J. Med. 2005. Vol. 325 (13). P. 1293–1304.Cavallari L. H. Sex Difference in the Antiplatelet Effect of Aspirin in Patients with Stroke // The Annals of Pharmacotherapy. 2005. Vol. 40, N 5. P. 812–817.Cavallari L. H. Sex Difference in the Antiplatelet Effect of Aspirin in Patients with Stroke // The Annals of Pharmacotherapy. 2005. Vol. 40, N 5. P. 812–817.Berger J. S., Bhatt D. L., Cannon C. P. et al. The Relative Safety and Efficacy of Clopidogrel in Women and Men: Meta-Analysis of 79, 613 Patients Enrolled in CREDO, CURE, CLARITY-TIMI 28, COMMIT, and CHARISMA // Circulation. 2007. Vol. 116 (II). P. 483–489.Berger J. S., Bhatt D. L., Cannon C. P. et al. The Relative Safety and Efficacy of Clopidogrel in Women and Men: Meta-Analysis of 79, 613 Patients Enrolled in CREDO, CURE, CLARITY-TIMI 28, COMMIT, and CHARISMA // Circulation. 2007. Vol. 116 (II). P. 483–489.Bandyopadhyay S., Bayer A. J., O’Mahony M. S. Age and gender bias in statin trials // QJM: An International Journal of Medicine. 2001. Vol. 94. P. 127–132.Bandyopadhyay S., Bayer A. J., O’Mahony M. S. Age and gender bias in statin trials // QJM: An International Journal of Medicine. 2001. Vol. 94. P. 127–132.Luzier A. B., Killian A., Wilton J. H. et al. Genderre lated effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers// Clin. Pharmacol. Ther. 1999. Dec. Vol. 66 (6). P. 594–601.Luzier A. B., Killian A., Wilton J. H. et al. Genderre lated effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers// Clin. Pharmacol. Ther. 1999. Dec. Vol. 66 (6). P. 594–601.Eisenberg T., Wells M. T. Statins and adverse cardiovascular events in moderate-risk females: a statistical and legal analysis with implications for FDA preemption claims // J. Empirical. Legal. Stud. 2008. Vol. 5. P. 507–550.Eisenberg T., Wells M. T. Statins and adverse cardiovascular events in moderate-risk females: a statistical and legal analysis with implications for FDA preemption claims // J. Empirical. Legal. Stud. 2008. Vol. 5. P. 507–550.Grady D., Chaput L., Kristof M. Results of systematic review of research on diagnosis and treatment of coronary heart disease in women. Evidence Report / Technology Assessment No. 80 // AHRQ Publication. 2003. May. N 03–0035.Grady D., Chaput L., Kristof M. Results of systematic review of research on diagnosis and treatment of coronary heart disease in women. Evidence Report / Technology Assessment No. 80 // AHRQ Publication. 2003. May. N 03–0035.Petretta M., Costanzo P., Perrone-Filardi P., Chiariello M. Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis // Int. J. Cardiol. 2008. Vol. 3. P. 23–28.Petretta M., Costanzo P., Perrone-Filardi P., Chiariello M. Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis // Int. J. Cardiol. 2008. Vol. 3. P. 23–28.Walsh J. M., Pignone M. Drug treatment of hyperlipidemia in women // JAMA. 2004. Vol. 291. P. 2243–2252.Walsh J. M., Pignone M. Drug treatment of hyperlipidemia in women // JAMA. 2004. Vol. 291. P. 2243–2252.Sever P. S., Poulter N. R., Dahlöf B. et al. the ASCOT investigators: Reduction in cardiovascular events with atorvastatin in 2,532 patients with Type 2 diabetes // Diabetes Care. 2005. Vol. 28. P. 1151–1157.Sever P. S., Poulter N. R., Dahlöf B. et al. the ASCOT investigators: Reduction in cardiovascular events with atorvastatin in 2,532 patients with Type 2 diabetes // Diabetes Care. 2005. Vol. 28. P. 1151–1157.Abramson J., Wright J. M. Are Statins Useful in Women and Older People? // The Lancet. 2008. Vol. 369, Issue 9557. P. 168–169.Abramson J., Wright J. M. Are Statins Useful in Women and Older People? // The Lancet. 2008. Vol. 369, Issue 9557. P. 168–169.Ridker P. M., Danielson E., Francisco A. H. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein // New Eng. J. Med. 2008. Vol. 21, November 20, Vol. 359. P. 2195–2207.Ridker P. M., Danielson E., Francisco A. H. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein // New Eng. J. Med. 2008. Vol. 21, November 20, Vol. 359. P. 2195–2207.Hague W., Forder P., Simes J. et al. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study // Am. Heart J. 2003. Apr. Vol. 145 (4). P. 643–651.Hague W., Forder P., Simes J. et al. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study // Am. Heart J. 2003. Apr. Vol. 145 (4). P. 643–651.LaRosa J. C., He J., Vupputuri S. Effect of Statins on Risk of Coronary Disease. A Meta-analysis of Randomized Controlled Trials // JAMA. 1999. Vol. 282. P. 2340–2346.LaRosa J. C., He J., Vupputuri S. Effect of Statins on Risk of Coronary Disease. A Meta-analysis of Randomized Controlled Trials // JAMA. 1999. Vol. 282. P. 2340–2346.Wilt T. J., Bloomfield H. E., MacDonald et al. Effectiveness of Statin Therapy in Adults With Coronary Heart Disease // Arch. Intern. Med. 2004. Vol. 164. P. 1427–1436.Wilt T. J., Bloomfield H. E., MacDonald et al. Effectiveness of Statin Therapy in Adults With Coronary Heart Disease // Arch. Intern. Med. 2004. Vol. 164. P. 1427–1436.Sacks F. M., Pfeffer M. A., Moye L. A. et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators // New Engl. J. Med. 1996. Oct. 3. Vol. 335 (14). P. 1001–1009.Sacks F. M., Pfeffer M. A., Moye L. A. et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators // New Engl. J. Med. 1996. Oct. 3. Vol. 335 (14). P. 1001–1009.Karp I., Chen S. F., Pilote L. Sex differences in the effectiveness of statins after myocardial infarction // CMAJ. 2007. Jan. Vol. 30, N 176 (3). P. 1503–1507.Karp I., Chen S. F., Pilote L. Sex differences in the effectiveness of statins after myocardial infarction // CMAJ. 2007. Jan. Vol. 30, N 176 (3). P. 1503–1507.Dale K. M., Coleman C. I., Shah S. A. et al. Impact of gender on statin efficacy // Curr. Med. Res. Opin. 2007. Mar. Vol. 23 (3). P. 565–574.Dale K. M., Coleman C. I., Shah S. A. et al. Impact of gender on statin efficacy // Curr. Med. Res. Opin. 2007. Mar. Vol. 23 (3). P. 565–574.Enriquez J. R., Pratap P., Zbilut J.P. et al. Women tolerate drug therapy for coronary artery disease as well as men do, but are treated less frequently with aspirin, beta-blockers, or statins // Gend. Med. 2008. Mar. Vol. 5 (1). P. 53–61.Enriquez J. R., Pratap P., Zbilut J.P. et al. Women tolerate drug therapy for coronary artery disease as well as men do, but are treated less frequently with aspirin, beta-blockers, or statins // Gend. Med. 2008. Mar. Vol. 5 (1). P. 53–61.Lahoz C., Mantilla T., Taboada M. et al. Gender differences in evidence-based pharmacological therapy for patients with stable coronary heart disease// Int. J. Cardiol. 2008. May 15. [Epub ahead of print]Lahoz C., Mantilla T., Taboada M. et al. Gender differences in evidence-based pharmacological therapy for patients with stable coronary heart disease// Int. J. Cardiol. 2008. May 15. [Epub ahead of print]Barrett-Connor E., Goodman-Gruen D. Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women // BMJ. 1995. Vol. 311. P. 1193–1196.Barrett-Connor E., Goodman-Gruen D. Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women // BMJ. 1995. Vol. 311. P. 1193–1196.Cauley J. A., Gutai J. P., Glynn N. W. et al. Serum estrone concentrations and coronary artery disease in postmenopausal women // Arterioscler. Thromb. Vasc. Biol. 1994. Vol. 14. P. 14–18.Cauley J. A., Gutai J. P., Glynn N. W. et al. Serum estrone concentrations and coronary artery disease in postmenopausal women // Arterioscler. Thromb. Vasc. Biol. 1994. Vol. 14. P. 14–18.Clarkson T. B. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression // Menopause. 2007. May-Jun. Vol. 14 (3), Pt 1. P. 373–384.Clarkson T. B. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression // Menopause. 2007. May-Jun. Vol. 14 (3), Pt 1. P. 373–384.Domburg R. T., Klootwijk P., Decckers J. W. et al. The Cardiac Injury Score as a Predictor for Long Term Mortality in Survivors of Myocardial Infarction // Eur. Heart J. 1998. Vol. 19. P. 1034–1041.Domburg R. T., Klootwijk P., Decckers J. W. et al. The Cardiac Injury Score as a Predictor for Long Term Mortality in Survivors of Myocardial Infarction // Eur. Heart J. 1998. Vol. 19. P. 1034–1041.

The authors declare that there are no conflicts of interest present.